NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

Doc, what biomarkers do you think would make for a relevant go/no-go here? Certainly none that have come up to date that are remotely predictive for DCVax.

If this is what it seems like, I’d imagine the “case by case” review would amount to “hey, this patient has GBM and likely dismal outcomes.” The cancer itself in this case would be the biomarker.

Hopefully this is all the sign of real movement from the regulators.